NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 1,573.00
+27.00 (1.75%)
Aug 12, 2026, 1:44 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 152.85 billion as of August 11, 2026. Its market cap has decreased by -74.74% in one year.
Market Cap
152.85B
Enterprise Value
105.93B
Revenue
608.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,573.00
ChartMarket Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 152.85B, a decrease of -97.91%. That is a compound annual growth rate of -51.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 152.85B | -62.34% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BINEX | 221.02B |
| GC Cell | 219.85B |
| EASY BIO,Inc. | 208.42B |
| HLB Therapeutics | 188.38B |
| Bioneer | 178.35B |
| Anterogen.Co.,Ltd. | 169.40B |
| JETEMA, | 162.20B |
| Helixmith | 156.56B |